Key points are not available for this paper at this time.
Beyond the ecosystem benefits of diversification through wheat–pea intercropping, this review analyzes the barriers and levers to its adoption and diffusion. The present review shows that structuring the value chain around the products of this innovative cropping system faces a set of technical (i.e., varietal selection, phytosanitary issue control, crop management sequence, collection management, and storage), economic (i.e., cost, price, market opportunities, and contracting), and public policy (i.e., subsidies for ecosystem services provided by intercropping) obstacles that contribute to its slow adoption and dissemination in Europe. However, the value chain resulting from the wheat–pea intercropping system has levers to be exploited at all levels, particularly in terms of its competitive advantages, ecosystem benefits, and superior product quality. The results of this review help to identify priorities that actors of the value chain can address to better focus their efforts on significant problems and solutions that can accelerate the adoption and dissemination of this agroecological system.
Mamine et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: